TrialCancer2010

Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508.

Joseph I Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.